Αποτελέσματα Αναζήτησης
In the United Kingdom since 2004, there has been a general trend away from using formocresol, driven by several factors: difficulty obtaining the medicament, concerns related to its safety, and promising clinical results of newer, nonaldehyde techniques. 318 However, the recent U.K. Clinical Guideline, Pulp Therapy for Primary Molars, still ...
Formocresol has been used in dentistry for over 100 years, and for vital pulpotomy in primary teeth for over 80 years. Its efficacy has been extensively studied, with clinical success rates ranging from 70% to 100%, making it the standard against which newer techniques are compared.
A chemical compound containing 35% cresol and 19% formalin in aqueous glycerine. It has been used to fix and disinfect pulp tissue during a pulpotomy procedure for primary teeth; however, serious concerns have been raised over the potential toxicity and cariogenicity of formalin and its possible blood-borne spread to distant sites.
3 Μαΐ 2023 · The current paper aimed to review the properties of formocresol and concerns regarding its safety as a pulpotomy medicament for primary teeth. With reference to the context of the recently...
Buckley introduced formocresol in 1904, which is the most commonly used medicament for pulpotomy. The success rate of formocresol pulpotomy ranged from 70 to 98%. 6 Histological findings observed with the use of formocresol ranged from slight inflammation to total degeneration and necrotic changes.
Formocresol has been used in dentistry since 100 years. The biologic approach to pediatric pulp therapy is either devitalization approach of formocresol pulptomy or pulpectomy. Formocresol was introduced to treat non-vital permanent teeth in the United States by Buckley in 1904. In 1930, Sweet introduced the formocresol pulpotomy
